May 08, 2025 / 04:00PM GMT
Operator
Hello and welcome to the Genmab financial results conference call for the first quarter of 2025. As a reminder, this conference call is being recorded.
During this telephone conference, you may be presented with forward-looking statements that include words such as beliefs, anticipates, plans, or expects. Actual results may differ materially, for example, as a result of the late or unsuccessful development projects.
Genmab is not under any obligation to update statements regarding the future, nor to confirm such statements in relation to actual results, unless this is required by law. Please also note that Genmab may hold your personal data as indicated by you as a part of our investor relations outreach activities in order to update you on Genmab going forward.
Please refer to our website for more information on Genmab and our privacy policy. I would not allow to hand the conference over to your first speaker today, Jan Van De Winkel. Please go ahead.
Jan van de Winkel - Genmab A/S-President - Chief
Q1 2025 Genmab A/S Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
